Anupam B. Jena : Citation Profile


Are you Anupam B. Jena?

Harvard University

8

H index

7

i10 index

206

Citations

RESEARCH PRODUCTION:

10

Articles

12

Papers

1

Chapters

RESEARCH ACTIVITY:

   18 years (2005 - 2023). See details.
   Cites by year: 11
   Journals where Anupam B. Jena has often published
   Relations with other researchers
   Recent citing documents: 7.    Total self citations: 12 (5.5 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pje47
   Updated: 2024-11-08    RAS profile: 2023-03-10    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Authors registered in RePEc who have co-authored more than one work in the last five years with Anupam B. Jena.

Is cited by:

Philipson, Tomas (16)

Lechner, Michael (14)

Basu, Anirban (13)

Lakdawalla, Darius (11)

Goldman, Dana (10)

boone, jan (8)

Williams, Heidi (6)

Pertile, Paolo (5)

Towse, Adrian (5)

Miraldo, Marisa (5)

Prettner, Klaus (4)

Cites to:

Philipson, Tomas (29)

Cutler, David (9)

Jones, Charles (8)

Nordhaus, William (7)

Romer, Paul (6)

Acemoglu, Daron (6)

Newhouse, Joseph (5)

Parry, Ian (5)

Goldman, Dana (5)

Shapiro, Jesse (5)

Kremer, Michael (4)

Main data


Where Anupam B. Jena has published?


Journals with more than one article published# docs
Journal of Health Economics4
Forum for Health Economics & Policy3

Working Papers Series with more than one paper published# docs
NBER Working Papers / National Bureau of Economic Research, Inc12

Recent works citing Anupam B. Jena (2024 and 2023)


YearTitle of citing document
2024The potential benefits of costly applications in grant contests. (2022). Myers, Kyle R. In: Papers. RePEc:arx:papers:2207.02379.

Full description at Econpapers || Download paper

2023Biased Beliefs and Stigma as Barriers to Treatment and Innovation Adoption. (2023). Lasio, Laura ; Grigolon, Laura. In: CRC TR 224 Discussion Paper Series. RePEc:bon:boncrc:crctr224_2023_277v2.

Full description at Econpapers || Download paper

2023The relevance of specification assumptions when analyzing the drivers of physical activity practice. (2023). Suarez, Maria Jose ; Garcia, Jaume. In: Economic Modelling. RePEc:eee:ecmode:v:119:y:2023:i:c:s0264999322003649.

Full description at Econpapers || Download paper

2023The price of cost-effectiveness thresholds under therapeutic competition in pharmaceutical markets. (2023). Straume, Odd Rune ; Dalen, Dag Morten ; Brekke, Kurt R. In: Journal of Health Economics. RePEc:eee:jhecon:v:90:y:2023:i:c:s0167629623000553.

Full description at Econpapers || Download paper

2024The relationship between monetary incentives, social status, and physical activity. (2024). Palma, Marco ; Kee, Jennifer Y ; Valdez, Natalia I ; Pruitt, Ross J. In: Journal of Behavioral and Experimental Economics (formerly The Journal of Socio-Economics). RePEc:eee:soceco:v:108:y:2024:i:c:s2214804323001817.

Full description at Econpapers || Download paper

2024Competition, value-based prices and incentives to research personalised drugs. (2024). Levaggi, Rosella. In: Socio-Economic Planning Sciences. RePEc:eee:soceps:v:93:y:2024:i:c:s0038012124000697.

Full description at Econpapers || Download paper

2023The price of cost-effectiveness thresholds. (2023). Straume, Odd Rune ; Dalen, Dag Morten ; Brekke, Kurt R. In: Discussion Paper Series in Economics. RePEc:hhs:nhheco:2023_004.

Full description at Econpapers || Download paper

Works by Anupam B. Jena:


YearTitleTypeCited
2011The Pragmatists Guide to Comparative Effectiveness Research In: Journal of Economic Perspectives.
[Full Text][Citation analysis]
article14
2011The Pragmatists Guide to Comparative Effectiveness Research.(2011) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 14
paper
2009`Me-Too Innovation in Pharmaceutical Markets In: Forum for Health Economics & Policy.
[Full Text][Citation analysis]
article7
2009Me-Too Innovation in Pharmaceutical Markets.(2009) In: NBER Chapters.
[Citation analysis]
This paper has nother version. Agregated cites: 7
chapter
2010The Contributions of Improved Therapy and Earlier Detection to Cancer Survival Gains, 1988-2000 In: Forum for Health Economics & Policy.
[Full Text][Citation analysis]
article4
2006Who Benefits from New Medical Technologies? Estimates of Consumer and Producer Surpluses for HIV/AIDS Drugs In: Forum for Health Economics & Policy.
[Full Text][Citation analysis]
article27
2005Who Benefits from New Medical Technologies? Estimates of Consumer and Producer Surpluses for HIV/AIDS Drugs.(2005) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 27
paper
2008Cost-effectiveness analysis and innovation In: Journal of Health Economics.
[Full Text][Citation analysis]
article23
2010An economic evaluation of the war on cancer In: Journal of Health Economics.
[Full Text][Citation analysis]
article24
2009An Economic Evaluation of the War on Cancer.(2009) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 24
paper
2010The economics of intense exercise In: Journal of Health Economics.
[Full Text][Citation analysis]
article33
2011The impact of comparative effectiveness research on health and health care spending In: Journal of Health Economics.
[Full Text][Citation analysis]
article19
2006Health Care, Technological Change, and Altruistic Consumption Externalities In: NBER Working Papers.
[Full Text][Citation analysis]
paper3
2006Surplus Appropriation from R&D and Health Care Technology Assessment Procedures In: NBER Working Papers.
[Full Text][Citation analysis]
paper9
2008The Value of Life in General Equilibrium In: NBER Working Papers.
[Full Text][Citation analysis]
paper8
2009Endogenous Cost-Effectiveness Analysis in Health Care Technology Adoption In: NBER Working Papers.
[Full Text][Citation analysis]
paper24
2014Does Medical Malpractice Law Improve Health Care Quality? In: NBER Working Papers.
[Full Text][Citation analysis]
paper8
2016Self-insuring against Liability Risk: Evidence from Physician Home Values in States with Unlimited Homestead Exemptions In: NBER Working Papers.
[Full Text][Citation analysis]
paper0
2019Is Great Information Good Enough? Evidence from Physicians as Patients In: NBER Working Papers.
[Full Text][Citation analysis]
paper1
2021How do Physicians Respond to Malpractice Allegations? Evidence from Florida Emergency Departments In: NBER Working Papers.
[Full Text][Citation analysis]
paper0
2023Occupational Hazard? An Analysis of Birth Outcomes Among Physician Mothers In: NBER Working Papers.
[Full Text][Citation analysis]
paper0
2010Altruism and Innovation in Health Care In: Journal of Law and Economics.
[Full Text][Citation analysis]
article2
2007The institute of medicine report on the FDA: where is the science? In: Health Economics.
[Full Text][Citation analysis]
article0

CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated November, 3 2024. Contact: CitEc Team